pubmed-article:20938119 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20938119 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20938119 | lifeskim:mentions | umls-concept:C0346647 | lld:lifeskim |
pubmed-article:20938119 | lifeskim:mentions | umls-concept:C0019061 | lld:lifeskim |
pubmed-article:20938119 | lifeskim:mentions | umls-concept:C0085533 | lld:lifeskim |
pubmed-article:20938119 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
pubmed-article:20938119 | lifeskim:mentions | umls-concept:C1533148 | lld:lifeskim |
pubmed-article:20938119 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:20938119 | pubmed:dateCreated | 2010-10-12 | lld:pubmed |
pubmed-article:20938119 | pubmed:abstractText | A 63-year-old man with Stage IVa pancreas tail cancer was admitted for a distal pancreatectomy and splenectomy; adjuvant chemotherapy with gemcitabine was also administered. The chemotherapy was terminated after 16 courses due to hemolytic anemia, thrombocytopenia and renal dysfunction. Plasma exchange was performed; however the patient's renal function was diminished, requiring chronic hemodialysis. Physicians should be cautious of hemolytic uremic syndrome as a possible adverse reaction to gemcitabine and be aware that tests are needed for its early detection. | lld:pubmed |
pubmed-article:20938119 | pubmed:language | jpn | lld:pubmed |
pubmed-article:20938119 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20938119 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20938119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20938119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20938119 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20938119 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20938119 | pubmed:month | Oct | lld:pubmed |
pubmed-article:20938119 | pubmed:issn | 0446-6586 | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:WatanabeSeish... | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:InabaTomokiT | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:KawaiKozoK | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:MiyoshiMasats... | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:BabaNobuyukiN | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:NaganoTakuyaT | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:SenohTomonori... | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:IshikawaHisas... | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:WatoMasakiM | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:IshikawaShige... | lld:pubmed |
pubmed-article:20938119 | pubmed:author | pubmed-author:TakaguchiKoic... | lld:pubmed |
pubmed-article:20938119 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:20938119 | pubmed:volume | 107 | lld:pubmed |
pubmed-article:20938119 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20938119 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20938119 | pubmed:pagination | 1676-85 | lld:pubmed |
pubmed-article:20938119 | pubmed:dateRevised | 2011-8-2 | lld:pubmed |
pubmed-article:20938119 | pubmed:meshHeading | pubmed-meshheading:20938119... | lld:pubmed |
pubmed-article:20938119 | pubmed:meshHeading | pubmed-meshheading:20938119... | lld:pubmed |
pubmed-article:20938119 | pubmed:meshHeading | pubmed-meshheading:20938119... | lld:pubmed |
pubmed-article:20938119 | pubmed:meshHeading | pubmed-meshheading:20938119... | lld:pubmed |
pubmed-article:20938119 | pubmed:meshHeading | pubmed-meshheading:20938119... | lld:pubmed |
pubmed-article:20938119 | pubmed:meshHeading | pubmed-meshheading:20938119... | lld:pubmed |
pubmed-article:20938119 | pubmed:meshHeading | pubmed-meshheading:20938119... | lld:pubmed |
pubmed-article:20938119 | pubmed:meshHeading | pubmed-meshheading:20938119... | lld:pubmed |
pubmed-article:20938119 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20938119 | pubmed:articleTitle | [A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer]. | lld:pubmed |
pubmed-article:20938119 | pubmed:affiliation | Department of Gastroentrology, Kagawa Prefectural Central Hospital. m-watou@chp-kagawa.jp | lld:pubmed |
pubmed-article:20938119 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20938119 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:20938119 | pubmed:publicationType | Review | lld:pubmed |
pubmed-article:20938119 | pubmed:publicationType | Case Reports | lld:pubmed |